EMB vs IBB
iShares JP Morgan USD Emerging Markets Bond ETF vs iShares Biotechnology ETF
- • EMB has the lower expense ratio at 0.39% vs 0.44% for IBB.
- • EMB pays a higher dividend yield (5.02%).
Side-by-side metrics
| Metric | EMB | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.39% | 0.44% |
Dividend yield Trailing 12-month yield. | 5.02% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $14.62B | $9.09B |
YTD return | 2.11% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.08 | 0.69 |
P/E ratio | — | 24.79 |
Last price | $96.00 | $196.62 |
Inception | — | — |
Issuer | iShares | iShares |
EMB top holdings
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 0.96% |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
About EMB
EMB (iShares JP Morgan USD Emerging Markets Bond ETF) is USD-denominated emerging market government bonds. Managed by iShares, the fund carries $14.6B in assets under management, an expense ratio of 0.39%, a dividend yield of 5.02%. Its largest holding is BlackRock Cash Funds Treasury SL Agency (XTSLA), which represents 1.0% of the portfolio.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.